Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Summary

The purpose of this study is to determine whether bilateral orthotopic lung transplantation (BOLT) followed by cadaveric partially-matched hematopoietic stem cell transplantation (HSCT) is safe and effective for patients aged 5-45 years with primary immunodeficiency (PID) and end-stage lung disease.

Timeline

Start

2013-06-20

Primary completion

2026-11

Completion

2027-11

Drugs

Indications